Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:46 AM
Ignite Modification Date:
2025-12-25 @ 2:46 AM
NCT ID:
NCT05348733
Eligibility Criteria:
Inclusion Criteria:
* Adult participants of all genders (≥18 years old)
* Diagnosis of CKD associated with T2D based on assessment by physician.
* Treatment according to local marketing authorization, finerenone 20 or 10 mg.Treatment should have been started up to 8 weeks before or after the ICF is signed.
* Decision to initiate treatment with finerenone must be made before ICF is signed.
* Signed informed consent
Exclusion Criteria:
* Participation in an investigational trial at any time during the course of this study
* Contra-indications according to the local label.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05348733
Study Brief:
Protocol Section:
NCT05348733